These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 19285289

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ.
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [Abstract] [Full Text] [Related]

  • 3. An explanatory model for state Medicaid per capita prescription drug expenditures.
    Roy S, Madhavan SS.
    Soc Work Public Health; 2012 Mar; 27(6):537-53. PubMed ID: 22963157
    [Abstract] [Full Text] [Related]

  • 4. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS, Miller GE.
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [Abstract] [Full Text] [Related]

  • 5. Prescription drug access: not just a Medicare problem.
    Cunningham PJ.
    Issue Brief Cent Stud Health Syst Change; 2002 Apr; (51):1-4. PubMed ID: 11977267
    [Abstract] [Full Text] [Related]

  • 6. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
    Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S.
    N Engl J Med; 1987 Aug 27; 317(9):550-6. PubMed ID: 3302713
    [Abstract] [Full Text] [Related]

  • 7. Lapses in Medicaid coverage: impact on cost and utilization among individuals with diabetes enrolled in Medicaid.
    Hall AG, Harman JS, Zhang J.
    Med Care; 2008 Dec 27; 46(12):1219-25. PubMed ID: 19300311
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.
    Fischer MA, Schneeweiss S, Avorn J, Solomon DH.
    N Engl J Med; 2004 Nov 18; 351(21):2187-94. PubMed ID: 15548779
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA, Winston FK, Kallan MJ, Branas CC, Schwartz JS.
    Ambul Pediatr; 2008 Nov 18; 8(1):58-65. PubMed ID: 18191783
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unintended outcomes of medicaid drug cost-containment policies on the chronically mentally ill.
    Soumerai S.
    J Clin Psychiatry; 2003 Nov 18; 64 Suppl 17():19-22. PubMed ID: 14680423
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors contributing to trends in prescription drug expenditures.
    Suh DC, Lacy CR, Barone JA, Moylan D, Kostis JB.
    Clin Ther; 1999 Jul 18; 21(7):1241-53. PubMed ID: 10463521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.